NEW YORK (GenomeWeb) – Sequenom has purchased intellectual property from Isis Innovations covering noninvasive prenatal testing for nearly $14.6 million, the company said today.

The deal includes $3.2 million as a final royalty payment under a previous licensing agreement and the waiver of $2.1 million in paid legal fees that Isis owed to Sequenom.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.